This document summarizes a presentation on next generation epigenetic profiling. It introduces epigenetics and how epigenetic changes like DNA methylation are important in causing cancer in addition to genetic changes. It discusses using methyl-binding domain sequencing to discover genome-wide methylation patterns and biomarkers. Examples are given of specific genes like MGMT and BRCA1 that show methylation changes in cancer. Integrating deep sequencing data with other assays is described to better understand methylation patterns and their effects on gene expression and cancer. Developing targeted panels of cancer-related genes with known epigenetic alterations is discussed for clinical applications.